Identify risk factors of developing post-surgical marginal ulceration in bariatric patients. Discuss the altered anatomy of RYGB patients and discuss how it can affect drug absorption. Understand the rationale of different formulations of proton pump inhibitors (PPI). Review different potencies of proton pump inhibitors and understand the PPI therapy optimization post-surgically.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- No reviews yet. Be the first to share yours.
- Journal-based
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Fee · varies
-
ReleasedMar 1, 2024
-
Last day to claim creditMar 2, 2027 5 months left
-
DrBeen Corp Proton Pump Inhibitors (Part 1) (PM 11)
-
Learner’s Digest International (TM) Nonbiologic Medical Therapies: Proton Pump Inhibitors and Topical Corticosteroids
-
American College of Chest Physicians October 2026: Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases
-
American Society for Metabolic and Bariatric Surgery May (B) 2026: Prevalence of early marginal ulcer in sleeve to bypass conversions: an analysis of the 2020 2022 MBSAQIP
-
American Society for Metabolic and Bariatric Surgery January 2025 (B): ASMBS literature review on the treatment of marginal ulcers after metabolic and bariatric surgery
-
American Society for Metabolic and Bariatric Surgery August 2026 (B): Conversion to Roux-en-Y gastric bypass as an effective treatment for postsleeve reflux: Identifying risk factors for persistent reflux
